"Safety, Tolerability and Pharmacokinetics of MP-376 Administered for 14 Days to Stable Pediatric (CF) Patients"

This study has been completed.
Sponsor:
Information provided by:
Mpex Pharmaceuticals
ClinicalTrials.gov Identifier:
NCT00840333
First received: February 5, 2009
Last updated: March 1, 2010
Last verified: March 2010
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2009
  Primary Completion Date: December 2009 (Final data collection date for primary outcome measure)